What MANLAB does

MANLAB is a private, family-owned Argentine reference clinical diagnostic laboratory founded in 1972, operating from a 1,600 m² central processing facility in Buenos Aires (Marcelo Torcuato de Alvear 2263, CABA) with continuous 24-hour operations. The company provides high-complexity testing through a catalog of more than 2,300 services spanning 17 specialty areas including clinical chemistry, endocrinology, genomic medicine, molecular infectious disease, histocompatibility, andrology, microbiology, toxicology and therapeutic drug monitoring. Each year it processes approximately 18.5 million tests on more than 36,000 daily patient samples referred by a network of over 2,000 associated laboratories across Argentina, supplemented by direct-patient services through facility-based and mobile sample collection. Since 2012, MANLAB has been one of three complementary Latin American partners of Mayo Clinic Laboratories, granting it localized access to Mayo's specialized test portfolio including RT-QuIC prion disease diagnostics, plasma biomarkers for Alzheimer's disease (pTau 217, alpha-synuclein) and other advanced neurology assays that are otherwise scarce in the region.

The underlying technology stack combines latest-generation diagnostic platforms—ATELLICA, ALINITY, COBAS and MAGNAPURE96 clinical chemistry and immunoassay systems; MISEQ-based next-generation sequencing; LC-MS/MS for therapeutic drug monitoring; and an inductively coupled plasma mass spectrometry (ICP-MS) platform deployed in April 2025 for trace metals (selenium, copper) analysis. Operational integration is delivered through LIS-BRISA, the company's proprietary laboratory information system, which provides referring laboratories with 24-hour remote test ordering and real-time validated result delivery. Sample logistics are managed by an 18-vehicle cold-chain fleet with electric refrigerators, GPS-monitored daily routes covering CABA, Greater Buenos Aires and other provinces, and end-to-end barcode-based traceability; pre-labeled barcode tubes are pre-positioned at referring laboratories nationwide. Quality posture is anchored by ISO 9001:2015 certification (IRAM), MA3 accreditation (Fundación Bioquímica Argentina) and INCUCAI Histocompatibilidad habilitation—the latter making MANLAB the only private laboratory in CABA outside a transplant unit authorized for HLA typing and anti-HLA antibody detection.

Revenue is generated per test processed on a transaction-fee basis across two complementary channels: a B2B referring-laboratory channel that supplies roughly the entire 36,000-sample-per-day volume, and a smaller B2C direct-patient channel for routine diagnostics, non-invasive prenatal testing (NIPT), the Gen360 consumer DNA panel and specialty genetic testing. Pricing is not publicly disclosed; rates are quote-based via the derivations platform to registered clients. In May 2026 the company executed a coordinated repricing across 361 key services, building on the 45% cost reduction in selenium and copper determinations enabled by the April 2025 ICP-MS deployment. Forward-looking positioning is reinforced through a free five-module online course ("Curso de Gestión Integral en el Laboratorio") running May–October 2026, covering laboratory management, equipment selection, AI applications and strategic data use, distributed through LinkedIn, Facebook and Instagram channels targeting the referring-laboratory base.

Name

MANLAB

Legal name

MANLAB

Website

https://manlab.com.ar

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

101–250 employees

Short description

MANLAB is a private, 50+ year-old Argentine reference clinical laboratory that processes roughly 18.5 million diagnostic tests per year across 2,300+ services for 2,000 referring laboratories and direct patients via a 24/7 1,600 m² facility anchored by its Mayo Clinic complementary partnership since 2012.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

• Clinical diagnostic services
• Genomic medicine testing
• Reference laboratory services
• Molecular diagnostics testing
• Pharmacogenetic testing

Headquarters

HQ city

Lomas De Zamora

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Laboratory Diagnostic Services: MANLAB generates revenue through processing clinical diagnostic tests for referring laboratories and healthcare providers across 2,300+ services in their catalog. Samples are received from 2,000 associated laboratories, processed in their 1,600 m² facility, and results delivered through their digital platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

MANLAB is a high-complexity reference clinical and genomic diagnostic laboratory that processes patient samples sent by a network of 2,000 associated laboratories across Argentina. Operating a 1,600 m² facility 24 hours a day, the company offers 2,300+ diagnostic tests across specialties including Clinical Chemistry, Endocrinology, Genomic Medicine, Molecular Infectious Disease, Histocompatibility, Andrology, Microbiology, Toxicology, and Cytology, with results returned in real time through the proprietary LIS-BRISA information system. Standalone branded offerings include Gen360 genetic testing, pharmacogenetic testing (TPMT and NUDT15), comprehensive dementia diagnostics in partnership with Mayo Clinic, neurofilament light chain biomarker testing, and non-invasive prenatal testing.

Product overview

MANLAB is a clinical diagnostic laboratory offering a comprehensive portfolio of approximately 2,300 medical tests across 17 specialty areas including Clinical Chemistry, Endocrinology, Genomic Medicine, Molecular Infectious Diseases, Histocompatibility, and more. The company operates a 1,600 m² processing plant 24 hours a day, handling over 36,000 patients daily from 2,000 associated laboratories. Key products include Gen360 DNA testing for genetic traits and ancestry, pharmacogenetic testing (TPMT/NUDT15) for personalized medicine, and comprehensive dementia diagnostics in partnership with Mayo Clinic. The company maintains advanced technological infrastructure including LIS-BRISA for sample tracking and a cold chain logistics system with GPS-monitored mobile units.

Differentiator

Problem solved

Functional benefit

Products and services

• Reference Laboratory Diagnostic Services High-complexity reference laboratory diagnostic processing across 2,300+ tests in 17 specialties for a network of 2,000 associated laboratories in Argentina. Operating a 1,600 m² facility 24/7, processing 36,000+ daily patient samples and 18.5 million tests annually, results delivered in real time via the proprietary LIS-BRISA platform.
• Gen360 DNA Genetic Test Consumer DNA test providing information on genetic variation related to physical traits, macronutrient and micronutrient metabolism, drug metabolism, and genetic markers for ancestry and relative identification. Targeted at individual consumers seeking personal genetic insights.
• Pharmacogenetic Testing (TPMT and NUDT15) Genotyping tests for thiopurine methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) genes that enable therapeutic individualization for patients receiving thiopurines, allowing dose adjustment and reducing risk of severe adverse effects.
• Dementia Diagnostics Panel Comprehensive diagnostic panel for dementia including Alzheimer's disease biomarker testing, autoimmune dementia evaluation, rapidly progressive dementia assessment, and Lewy body dementia/Parkinson's/multiple system atrophy testing, delivered through the Mayo Clinic partnership.
• Neurofilament Light Chain (NfL) Testing Neurofilament light chain biomarker testing used for traumatic brain injury evaluation, assessing recovery from acute brain trauma and monitoring progression in chronic cases.
• Non-Invasive Prenatal Testing (NIPT) Non-invasive prenatal test analyzing free fetal DNA in maternal blood for safe and reliable prenatal evaluation, available to pregnant patients.
• Metals Analysis Service (Selenium, Copper via ICP-MS) Trace metals analysis service using latest-generation ICP-MS technology to provide precise, rapid, and reliable measurement of metals including Selenium and Copper across complex matrices and wide concentration ranges with minimized interferences.

Quantifiable outcome

• 45% cost reduction on Selenium and Copper determinations following ICP-MS implementation
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Mayo CliniccoreStrategic or Co-development Partner · 1 January 2012MANLAB is one of three complementary partners of Mayo Clinic Laboratories in Latin America since 2012. This partnership enables MANLAB to offer Mayo Clinic's testing portfolio to healthcare professionals and patients in Argentina, including advanced dementia biomarkers, prion disease testing (RT-QuIC), and other specialized tests developed by Mayo Clinic.
• CentogeneminorStrategic or Co-development PartnerInternational partnership for specialized genetic and rare disease testing services.
• Fundación Creutzfeldt-JakobminorStrategic or Co-development PartnerInternational partnership for prion disease testing and research support.
• Baylor College of MedicineminorStrategic or Co-development PartnerInternational academic partnership for genetic testing and molecular diagnostics.
• Quest DiagnosticsminorStrategic or Co-development PartnerInternational laboratory partnership for diagnostic services.

Scale indicators9 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Synlab: Europe's largest medical diagnostics services provider with growing LATAM operations, offering reference laboratory, specialty testing, and clinical trial support. Comparable reference-lab operating model at substantially greater scale.
• Quest Diagnostics: Global reference laboratory leader offering esoteric and routine diagnostic testing across the Americas. Listed as one of MANLAB's international partners, but a much larger incumbent that could expand into the LATAM reference market MANLAB serves.
• Mayo Clinic Laboratories: Reference laboratory of Mayo Clinic offering an extensive specialty test menu and serving as the upstream content partner (since 2012) for MANLAB and two other LATAM complementary partners. Strategic partner that also represents a competitive benchmark for menu breadth.
• Laboratory Corporation of America (Labcorp): US-headquartered clinical laboratory network with international reach and a strong esoteric/reference testing franchise. Serves as a benchmark for the operating model MANLAB emulates at LATAM regional scale.

Others

• bioMérieux: Global in vitro diagnostics manufacturer and clinical microbiology solutions provider with relevance to MANLAB as a supplier of microbiology and immunoassay platforms (related to MANLAB's equipment base). Not a direct competitor but adjacent ecosystem participant.

Direct peers

• CENTOGENE: Specialized genetic and rare disease diagnostics company with international reference lab operations. Listed as a MANLAB partner for genetic/rare disease testing, while also competing directly in the genetic diagnostics space.
• Diagnóstico Maipú (Grupo Oroño): Major Argentine diagnostics network (now part of Grupo Oroño) providing imaging and laboratory services with reference-lab capabilities. Directly comparable in serving physicians, patients, and corporate health accounts across Argentina.
• Stamboulian Laboratories: Argentine reference laboratory offering specialized clinical diagnostics across infectious disease, genetic, and molecular testing to referring physicians and labs. Closest direct domestic competitor with similar hub-and-spoke reference model and B2B/B2C channel mix.

Emerging players

• Natera: Specialized molecular diagnostics company focused on cell-free DNA applications including NIPT and oncology. Directly comparable to MANLAB's NIPT and pharmacogenetic offerings in the genetic/molecular reproductive health segment.

Regional players

• Hospital Italiano de Buenos Aires (Laboratory): Academic medical center with in-house laboratory performing high-complexity diagnostics for affiliated physicians in Argentina. Comparable for genomic and specialized diagnostics capabilities within a vertically integrated provider network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/LaboratorioMANLAB
• LinkedInlinkedin.com/company/laboratorio-mantel
• Instagraminstagram.com/laboratoriomanlab

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MANLAB